US Patent Issued to Akston Biosciences on Sept. 22 for "Insulin-Fc fusion proteins and methods of use to treat cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,000, issued on Sept. 22, was assigned to Akston Biosciences Corp. (Beverly, Mass.).

"Insulin-Fc fusion proteins and methods of use to treat cancer" was invented by Todd C. Zion (Salem, Mass.) and Thomas M. Lancaster (Wenham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions of fusion proteins, e.g., insulin-Fc fusion proteins, and their use to treat cancer cells and cancer tumors."

The patent was filed on May 3, 2023, under Application No. 18/311,585.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...